| Trial ID: | L3090 |
| Source ID: | NCT01043965
|
| Associated Drug: |
Metformin
|
| Title: |
Myocardial Perfusion in Type 2 Diabetes
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes
|
| Interventions: |
DRUG: Metformin
|
| Outcome Measures: |
Primary: myocardial blood flow velocity, myocardial blood flow reserve, 3 months |
|
| Sponsor/Collaborators: |
Sponsor: University of Sao Paulo General Hospital | Collaborators: Fundação de Amparo à Pesquisa do Estado de São Paulo
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE1|PHASE2
|
| Enrollment: |
61
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: SINGLE (INVESTIGATOR)|Primary Purpose: DIAGNOSTIC
|
| Start Date: |
2005-08
|
| Completion Date: |
2009-08
|
| Results First Posted: |
|
| Last Update Posted: |
2010-01-07
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT01043965
|
